Introduction
============

Renal tubulointerstitial injury often results in tubular atrophy and interstitial fibrosis, which is a major histopathological entity of renal senescence and a common pathological pathway to end-stage renal failure in almost all renal diseases (Barnes & Glass, [@b4]). Tubular atrophy is caused by inflammation and apoptosis, whereas interstitial fibrosis is caused by excessive accumulation of extracellular matrix (ECM) (Djamali, [@b16]). Recently, the epithelial-to-mesenchymal transition (EMT) and the activation of major profibrosis factors have been investigated in renal tubulointerstitial injury. Transforming growth factor-β1 (TGF-β1), as the most potent inducer of EMT, initiates and directs the entire EMT course, mainly through the TGF-β1/Smad signal pathway (Liu, [@b25]). Angiotensin II causes renal tubulointerstitial injury deterioration by regulating profibrotic and proinflammative factors including nuclear factor-kappa B (NF-κB), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) (Dussaule *et al*., [@b17]; Samarakoon *et al*., [@b35]). Developing cause-specific treatment strategies to ameliorate renal tubulointerstitial injury is a major challenge.

B lymphoma Mo-MLV insertion region 1 (Bmi-1), a member of the polycomb family of transcriptional repressors, is involved in cell cycle regulation and cell senescence by inhibiting p16^INK4a^/Rb and p19^AFR^/p53 pathways (Zhang *et al*., [@b45]). Bmi-1 is also involved in mitochondrial function maintenance and DNA protection from damage. Increased and persistent high levels of ROS caused by impaired mitochondrial function are sufficient to induce organism senescence via DNA damage in *Bmi-1* null mice (Liu *et al*., [@b26]). The thymocyte maturation defect characteristic of Bmi-1-deficient mice is largely rescued by treatment with antioxidants. Previous studies reported that oxidative stress plays an important role in the pathogenesis of renal tubulointerstitial injury (Djamali, [@b16]). The tubules of the tubulointerstitium are particularly susceptible to oxidative stress injury because of their high metabolic rate and limited antioxidant defenses (Hodgkins & Schnaper, [@b20]; Small *et al*., [@b37]). However, it is unclear whether Bmi-1 deficiency could lead to renal tubulointerstitial injury by mitochondrial dysfunction and increased ROS production in kidney.

To answer this question, *Bmi-1*^*-/-*^ mice were treated with the antioxidant N-acetylcysteine (NAC, 1 mg mL^−1^) in their drinking water or pyrro-quinoline quinone (PQQ, 4 mg kg^−1^ diet) in their diet. Their renal phenotype was then compared with that of vehicle-treated *Bmi1*^*-/-*^ and wild-type mice.

Results
=======

Renal interstitial fibrosis is ameliorated by NAC treatment in *Bmi-1*^*-/-*^ mice
----------------------------------------------------------------------------------

*Bmi-1*^*-/-*^ mice had significantly decreased survival rates (Fig. [1A](#fig01){ref-type="fig"} and Table [S3](#sd2){ref-type="supplementary-material"}). The size of both the body and kidney, and renal thickness ratios for cortex/total and cortex/medulla were decreased; however, the medulla/total thickness ratio was not altered in *Bmi-1*^*-/-*^ mice (Fig. [1B--E](#fig01){ref-type="fig"}). The positive areas of total collagen, Masson's trichrome-labeled interstitial fibers, type I collagen, α-smooth muscle actin (α-SMA) and fibronectin, the mRNA expression levels of α -SMA and fibronectin, and the protein expression levels of α-SMA in kidneys were increased significantly in *Bmi-1*^*-/-*^ mice, compared with wild-type mice (Figs [1F--P](#fig01){ref-type="fig"} and [S1A,B](#sd1){ref-type="supplementary-material"}). Electron micrographs showed that hemorrhage, fibroblasts, and collagen fibrils were observed in the tubular interstitium of *Bmi-1*^*-/-*^ mice (Fig. [1Q](#fig01){ref-type="fig"}). The NAC treatment prolonged the lifespan (Fig. [1A](#fig01){ref-type="fig"}), increased the sizes of the body and kidney (Fig. [1B,C](#fig01){ref-type="fig"}) and renal thickness ratios for cortex/total and cortex/medulla (Fig. [1D,E](#fig01){ref-type="fig"}), decreased the renal fibrosis related parameters (Fig. [1F--P](#fig01){ref-type="fig"}), and improved the microstructure of tubular interstitium (Fig. [1Q](#fig01){ref-type="fig"}).

![Renal interstitial fibrosis was ameliorated by N-acetylcysteine (NAC) treatment in *Bmi-1*^*-/-*^ mice. (A) Percent survival of vehicle-treated wild-type (WT) and *Bmi-1*^*-/-*^ mice (KO) and NAC-treated *Bmi-1*^*-/-*^ mice (KO+NAC). (B) Representative appearance and (C) kidney from 5-week-old WT, KO, and KO+NAC mice. (D) Representative micrographs of longitudinal sections of the kidneys stained with HE. (E) Thickness ratios for cortex/total, medulla/total, and cortex/medulla. (F) α-SMA and fibronectin mRNA relative levels in kidneys determined by real-time RT--PCR, calculated as a ratio to GAPDH mRNA, expressed relative to WT. Representative micrographs of paraffin-embedded kidney sections stained histochemically for (G) total collagen, (H) Masson's trichrome, and immunohistochemically for (I) type Ι collagen (Col I), (J) α-smooth muscle actin (α-SMA) and (K) fibronectin. The percentage of (L) total collagen (Total Col), (M) interstitial fibers demonstrated by Masson's trichrome stain, (N) Col I, (O) α-SMA, and (P) fibronectin-positive areas. (Q) Electron micrograph of kidney sections from WT, KO, and KO+NAC mice. Blue arrows: fibroblasts; yellow arrows: collagen fibrils; red arrows: hemorrhage in interstitium. Values are mean ± SEM of six determinations of each group. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 compared with WT. \#*P* \< 0.05; \#\#*P* \< 0.01; \#\#\#*P* \< 0.001 compared with KO group.](acel0013-0797-f1){#fig01}

Tubular atrophy is improved by NAC treatment in *Bmi-1*^*-/-*^ mice
-------------------------------------------------------------------

E-cadherin-positive renal tubules and the percentage of Ki67 positive renal cells were clearly decreased, whereas the percentages of senescence-associated-β-gal (SA-β-gal) positive area and TUNEL-positive cells were increased significantly in *Bmi-1*^*-/-*^ mice, compared with wild-type mice (Fig. [2A--H](#fig02){ref-type="fig"}). The mRNA levels of B-cell lymphoma-extra large (Bcl-xl), protein levels of E-cadherin, pAkt relative to Akt, and Bcl-2 were down-regulated, whereas the mRNA levels of Bcl-2-associated X protein (Bax), protein levels of caspase-3, and phospho-caspase-3 (pcaspase-3) were clearly up-regulated in *Bmi-1*^*-/-*^ mice, compared with wild-type mice (Fig. [2I--L](#fig02){ref-type="fig"}). In addition, inflammatory cells and granulomas in the tubulointerstitium and vacuolar degeneration were displayed in the tubular epithelial cells of *Bmi-1*^*-/-*^ mice (Fig. [3A](#fig03){ref-type="fig"}). The percentages of NF-κB-p65-positive cells, IL-6, and TNF-α-positive areas, mRNA expression levels of NF-κB, IL-6, and TNF-α, and the percentage of CD11b-positive and CD3e-positive inflammatory cells in kidneys were increased significantly in *Bmi-1*^*-/-*^ mice, compared with wild-type mice (Fig. [3B--J](#fig03){ref-type="fig"}). Renal tubule atrophy (Fig. [2A,E](#fig02){ref-type="fig"}), decreased renal cell proliferation (Fig. [2B,F](#fig02){ref-type="fig"}), increased renal cell senescence (Fig. [2C,G](#fig02){ref-type="fig"}, apoptosis (Fig. [2D,H](#fig02){ref-type="fig"}), related molecular alterations (Fig. [2I--M](#fig02){ref-type="fig"}), increased inflammatory cell infiltration, and related inflammatory factors (Fig. [3](#fig03){ref-type="fig"}) in Bmi-1-deficient kidneys were largely rescued by the NAC treatment.

![Tubular atrophy-associated proapoptosis and aging were ameliorated by N-acetylcysteine (NAC) treatment in *Bmi-1*^*-/-*^ mice. Representative micrographs of paraffin embedded kidney sections from 5-week-old vehicle-treated wild-type (WT) and *Bmi-1*^*-/-*^ mice (KO) and NAC-treated *Bmi-1*^*-/-*^ mice (KO+NAC) stained immunohistochemically for (A) E-cadherin, (B) Ki67, (C) senescence-associated-β-galactosidase (SA-β-gal), and (D) TUNEL. Red arrows: positive nuclei. The percentages of (E) E-cadherin-positive area, (F) Ki67-positive cells, (G) SA-β-gal-positive area, and (H) TUNEL-positive cells relative to total cells/areas. (I) Bcl-xl and Bax mRNA relative levels in kidneys demonstrated by real-time RT--PCR, calculated as a ratio to GAPDH mRNA, expressed relative to WT. Western blots of kidney extracts for expression of (J) E-cadherin, Akt, pAkt, Bcl-2, (K) caspase-3 and pcaspase-3, with β-actin as a loading control. (L) The above protein levels relative to β-actin protein levels were assessed by densitometric analysis. Values are means ± SEM of six determinations of each group. \*\**P* \< 0.01; \*\*\**P* \< 0.001 compared with WT. \#*P* \< 0.05; \#\#*P* \< 0.01; \#\#\#*P* \< 0.001 compared with KO.](acel0013-0797-f2){#fig02}

![Tubular atrophy-associated proinflammation was ameliorated by N-acetylcysteine (NAC) treatment in *Bmi-1*^*-/-*^ mice. Representative micrographs of paraffin embedded kidney sections from 5-week-old vehicle-treated wild-type (WT) and *Bmi-1*^*-/-*^ mice (KO) and NAC-treated *Bmi-1*^*-/-*^ mice (KO+NAC) stained with (A) HE, immunohistochemically for (B) NF-κB, (C) TNF-α, and (D) IL-6. Red arrows: inflammatory cells and granulomas. Blue arrows: vacuolar degeneration. The percentages of (E) NF-κB-p65-positive cells, (F) TNF-α-positive areas, and (G) IL-6-positive areas relative to total cells/areas. (H) NF-κB, IL-6 and TNF-α mRNA relative levels in kidneys demonstrated by real-time RT--PCR, calculated as a ratio to GAPDH mRNA, expressed relative to WT. (I) Flow cytometry analysis of cells from kidneys of 5-week-old WT, *Bmi-1*^*-/-*^ mice (KO), and *Bmi-1*^*-/-*^ mice with NAC (KO+NAC) for CD11b and CD3e. (J) Measurements for CD11b- and CD3e-positive cells relative to total cells. Values are means ± SEM of six determinations of each group. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 compared to WT. \#*P* \< 0.05; \#\# *P* \< 0.01 compared with KO.](acel0013-0797-f3){#fig03}

Impaired mitochondrial structure and redox imbalance in kidney are ameliorated by NAC treatment in *Bmi-1*^*-/-*^ mice
----------------------------------------------------------------------------------------------------------------------

It was observed in electron micrographs that renal tubular epithelial cells from *Bmi-1*^*-/-*^ mice displayed a brush border disorder, mitochondrial number reduction, swelling and cristae vague, vacuolized and lipid droplets (Fig. [4A,B](#fig04){ref-type="fig"}). The levels of intracellular ROS, hydrogen peroxide (H~2~O~2~), and malondialdehyde (MDA) were increased dramatically, whereas the activities of total superoxide dismutase (T-SOD) and catalase (CAT), the mRNA levels of glutathione peroxidase (Gpx1), glutathione reductase (GSR), CAT, SOD2 and peroxiredoxin1 (Prdx1), and the protein levels of SOD2 and Prdx1 were down-regulated significantly. However, SOD1 mRNA and protein expression levels were not altered in *Bmi-1*^*-/-*^ mice, compared with WT mice (Fig. [4C--J](#fig04){ref-type="fig"}). Mitochondrial number reduction, swelling and cristae vague, and vacuolized and lipid droplets in renal tubular epithelial cells were ameliorated in NAC-treated *Bmi-1*^*-/-*^ mice, demonstrated by electron microscopy (Fig. [4A,B](#fig04){ref-type="fig"}). Compared with vehicle-treated *Bmi-1*^*-/-*^ mice, the levels of intracellular ROS, H~2~O~2~, and MDA were decreased significantly, whereas the activity of CAT, the mRNA levels of Gpx1, and CAT were up-regulated significantly in NAC-treated *Bmi-1*^*-/-*^ mice (Fig. [4C--J](#fig04){ref-type="fig"}).

![Impaired mitochondrial structure and redox imbalance in kidney were ameliorated by N-acetylcysteine (NAC) treatment in *Bmi-1*^*-/-*^ mice. (A) Representative electron micrographs of kidney sections from 5-week-old vehicle-treated wild-type (WT) and *Bmi-1*^*-/-*^ mice (KO) and NAC-treated *Bmi-1*^*-/-*^ mice (KO+NAC). Black arrowheads: vacuolized mitochondria (serious swelling); white arrowheads: brush border of renal tubular epithelial cells; black arrows: mitochondria swelling and cristae vague; white arrows: lipid droplets. (B) Quantification of mitochondria numbers. Mitochondria were quantificated from 2 distinct 25 μm^2^ regions per cell from 2 cells per animal from at least 3 different animals per genotype. (C) ROS in kidneys from the three groups of 5-week-old mice by flow cytometry. (AF: auto fluorescence) (D) Measurements for ROS. Concentrations of (E) malondialdehyde (MDA), (F) hydrogen peroxide (H~2~O~2~), (G) total superoxide dismutase (T-SOD), and catalase (CAT) determined by spectrophotometry. (H) Glutathione peroxidase 1 (Gpx1), glutathione reductase (GSR), CAT, SOD1, SOD2, and peroxiredoxin1 (Prdx1) mRNA relative levels in kidneys demonstrated by real-time RT--PCR, calculated as a ratio to GAPDH mRNA, expressed relative to WT. (I) Western blots of kidney extracts for expression of SOD-1, SOD-2, and Prdx1. β-actin was used as a loading control. (J) The above protein levels relative to β-actin protein levels were assessed by densitometric analysis. Values are means ± SEM of six determinations of each group. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 compared with WT. \#*P* \< 0.05; \#\#*P* \< 0.01; \#\#\#*P* \< 0.001 compared with KO.](acel0013-0797-f4){#fig04}

DNA damage in kidney is ameliorated by NAC treatment in *Bmi-1*^*-/-*^ mice
---------------------------------------------------------------------------

The percentages of γ-H2A.X, 8-hydroxydeoxyguanosine (8-OHdG), 53Bp1 and phosphorylated checkpoint kinase 2 (pCHK2)-positive cells, and protein expression levels of γ-H2A.X, pCHK2, p16, p19, p53, and p21 in kidneys were increased significantly in *Bmi-1*^*-/-*^ mice, compared with wild-type mice (Figs [5A--H](#fig05){ref-type="fig"} and [S1C--F](#sd1){ref-type="supplementary-material"}). Compared with vehicle-treated *Bmi-1*^*-/-*^ mice, these DNA damage related parameters in kidneys was decreased dramatically in NAC-treated *Bmi-1*^*-/-*^ mice, although they were not normalized (Figs [5A--H](#fig05){ref-type="fig"} and [S1C,D](#sd1){ref-type="supplementary-material"}). The gene expression levels of p16, p19, p53, and p21 were up-regulated, whereas the gene expression levels of cyclin D1 and CDK4 were down-regulated in untreated Bmi-1-deficient kidneys, although there was insignificant regulation by NAC treatment (Fig. [S1G](#sd1){ref-type="supplementary-material"}).

![Renal DNA damage and impaired renal function were ameliorated by N-acetylcysteine (NAC) treatment in *Bmi-1*^*-/-*^ mice. Representative micrographs of paraffin embedded kidney sections from 5-week-old vehicle-treated wild-type (WT) and *Bmi-1*^*-/-*^ mice (KO) and NAC-treated *Bmi-1*^*-/-*^ mice (KO+NAC) stained immunohistochemically for (A) γ-H2A.X, (B) 8-hydroxydeoxyguanosine (8-OHdG), (C) 53Bp1 and (D) phosphorylated checkpoint kinase 2 (pCHK2). The positive cell percentages of (E) γ-H2A.X, (F) 8-OHdG, (G) 53Bp1, and (H) pCHK2 relative to total cells. (I) Color Doppler flow imaging of peak systolic velocity (PSV) for kidneys from 5-week-old vehicle-treated wild-type (WT) and *Bmi-1*^*-/-*^ mice (KO) and NAC-treated *Bmi-1*^*-/-*^ mice (KO+NAC). (J) Measurements for PSV. (K) 1α-hydroxylase e(1α(OH)ase) and erythropoietin (EPO) mRNA relative levels in kidneys demonstrated by real-time RT--PCR, calculated as a ratio to GAPDH mRNA, expressed relative to WT. (L) The percentage of hematocrit. (M) Serum creatinine clearance (SCrCl) levels relative to WT, (N) urine creatinine (UCr), (O) serum urea nitrogen (SUN) concentrations, (P) serum creatinine (SCr) levels, and (Q) urinary albumin (UAL) levels were determined by spectrophotometry. Values are means ± SEM of six determinations of each group. \**P* \< 0.05; \*\**P* \< 0.05; \*\*\**P* \< 0.001 compared with WT. \#*P* \< 0.05; \#\#*P* \< 0.01; \#\#\#*P* \< 0.001 compared with KO.](acel0013-0797-f5){#fig05}

Impaired renal function is ameliorated by NAC treatment in *Bmi-1*^*-/-*^ mice
------------------------------------------------------------------------------

Renal peak systolic velocity (PSV) detected by Color Doppler flow imaging, the mRNA expression levels of renal 1α-hydroxylase (1α(OH)ase) and erythropoietin (EPO), the percentage of hematocrit, the levels of serum creatinine clearance (SCrCl), and urine creatinine (UCr) were obviously decreased, whereas the levels of serum urea nitrogen (SUN), serum creatinine (SCr), and urinary albumin (UAL) were increased significantly in *Bmi-1*^*-/-*^ mice, compared with wild-type mice (Fig. [5I--Q](#fig05){ref-type="fig"}). Compared with vehicle-treated *Bmi-1*^*-/-*^ mice, renal PSV, the mRNA expression levels of renal 1α(OH)ase and EPO, the percentage of hematocrit, and the levels of SCrCl and UCr were increased significantly, whereas the levels of SUN, SCr, and UAL were reduced significantly in NAC-treated *Bmi-1*^*-/-*^ mice (Fig. [5I--Q](#fig05){ref-type="fig"}).

Activation of TGF-β signaling and imbalance between ECM synthesis and degradation are ameliorated by NAC treatment in *Bmi-1*^*-/-*^ mice
-----------------------------------------------------------------------------------------------------------------------------------------

TGF-β signaling molecules, the renin--angiotensin--aldosterone (ALD) system (RAAS), ECM synthesis, and degradation-related molecules in kidneys were examined in NAC-treated *Bmi-1*^*-/-*^ mice and vehicle-treated *Bmi-1*^*-/-*^ and wild-type mice. When compared with the wild-type mice, mRNA expression levels of renin and angiotensinogen (aogen) (Fig. [6A](#fig06){ref-type="fig"}), the plasmic angiotensin II (Ang II) and ALD levels (Fig. [6B](#fig06){ref-type="fig"}), and the protein expression levels of activated TGF-β1, TGF-βRII, pSmad2/3, Smad4, and Ang II (Fig. [6C,D](#fig06){ref-type="fig"}) were increased significantly, whereas the mRNA expression levels of TGF-β1 and Ang II receptor type 1 (AT1) (Fig. [6A](#fig06){ref-type="fig"}), and TGF-β1 precursor protein levels (Fig. [6C](#fig06){ref-type="fig"}) were not altered in *Bmi-1*^*-/-*^ mice. The renal ECM degradation-related gene matrix metalloproteinases 9 (MMP9) and ratios of MMP2/tissue inhibitor of metalloproteinase 2 (TIMP2), MMP9/TIMP1 mRNA were decreased. However, the renal ECM antidegradation-related genes, TIMP1, TIMP2, and plasminogen activator inhibitor-1 (PAI-1) (Fig. [6E](#fig06){ref-type="fig"}), and synthesis-related gene α-SMA were increased in *Bmi-1*^*-/-*^ mice (Fig. [1F](#fig01){ref-type="fig"}). Compared with the vehicle-treated *Bmi-1*^*-/-*^ mice, RAAS and TGF-β1/Smad signaling-related parameters were decreased significantly (Fig. [6A--D](#fig06){ref-type="fig"}), and the renal ECM degradation-related gene MMP9 and ratios of MMP2/TIMP2, MMP9/TIMP1 mRNA were increased. However, the renal ECM antidegradation-related genes TIMP1, TIMP2, and PAI-1 (Fig. [6E](#fig06){ref-type="fig"}) and synthesis-related gene α-SMA (Fig. [1F](#fig01){ref-type="fig"}) were decreased in NAC-treated *Bmi-1*^*-/*-^ mice.

![Activation of TGF-β signaling and imbalance between ECM synthesis and degradation were ameliorated by N-acetylcysteine (NAC) treatment in *Bmi-1*^*-/-*^ mice. (A) Transforming growth factor-β1 (TGF-β1), renin, angiotensinogen (aogen), angiotensin II (Ang II) receptor type 1 (AT1) mRNA relative levels in kidneys demonstrated by real-time RT--PCR, calculated as a ratio to GAPDH mRNA, expressed relative to WT. (B) Plasma Ang II and aldosterone (ALD) levels measured by radioimmunoassay. (C) Western blots of kidney extracts for expression of TGF-β1 precursor, activated TGF-β1, transforming growth factor-β receptor II (TGF-βRII), pSmad2/3, Smad4, Ang II. β-actin was the loading control. (D) The above protein levels relative to β-actin protein levels were assessed by densitometric analysis. (E) Matrix metalloproteinases 2 (MMP2), MMP9, tissue inhibitor of metalloproteinase 1 (TIMP1), TIMP2, ratios of MMP2/TIMP2, MMP9/TIMP1, and plasminogen activator inhibitor-1 (PAI-1) mRNA relative levels in kidneys demonstrated by real-time RT--PCR, calculated as a ratio to GAPDH mRNA, expressed relative to WT. Values are means ± SEM of six determinations of each group. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 compared with WT. \#*P* \< 0.05; \#\#*P* \< 0.01 compared with KO.](acel0013-0797-f6){#fig06}

Enhanced EMT induced by oxidative stress is ameliorated by NAC treatment in Bmi-1-knockdown HK2 cells
-----------------------------------------------------------------------------------------------------

Bmi-1 was knocked down in human renal proximal tubular epithelial (HK2) cells that were cultured with or without NAC. Oxidative stress and EMT-related parameters were examined by real-time RT--PCR and immunocytochemistry. Bmi-1 gene expression levels were down-regulated to 25.2%, 29.4%, and 28.1% of negative control in Bmi-1 siRNA1, 2 and 3 transfected cells (Fig. [S2A, B](#sd1){ref-type="supplementary-material"}), respectively. β-actin gene expression levels were down-regulated to 23.9% in β-actin siRNA-transfected cells, but not altered in Bmi-1 siRNA1, 2 and 3 transfected cells (Fig. [S2C,D](#sd1){ref-type="supplementary-material"}). These results demonstrate that Bmi-1 was knocked down successfully in HK2 cells. Compared with the negative control, intracellular ROS and α-SMA-positive cells were increased dramatically, whereas Bmi-1 protein, E-cadherin-positive cells, and SOD1, SOD2, Gpx1, Gpx4, and GSR mRNA levels were decreased in Bmi-1 knockdown HK2 cells (Fig. [S2E--L](#sd1){ref-type="supplementary-material"}). Compared with vehicle-treated Bmi-1 knockdown HK2 cells, intracellular ROS and α-SMA-positive cells were decreased, whereas Bmi-1 protein, E-cadherin-positive cells, and SOD2 and Gpx1 mRNA levels were increased in NAC-treated Bmi-1 knockdown HK2 cells (Fig. [S2E--L](#sd1){ref-type="supplementary-material"}).

Renal tubulointerstitial injury is ameliorated by PQQ treatment in *Bmi-1*^*-/-*^ mice
--------------------------------------------------------------------------------------

To further investigate whether renal tubulointerstitial injury caused by Bmi-1 deficiency was due to oxidative damage to tissues and cells, 3-week-old *Bmi-1*^-/-^ mice were treated with the antioxidant pyrro-quinoline quinone (PQQ, 4 mg kg^−1^ diet) in their diet for 2 weeks. Compared with untreated *Bmi-1*^*-/-*^ mice, the PQQ-treated *Bmi-1*^*-/-*^ mice increased the sizes of the body and kidney (Fig. [S3A,B](#sd1){ref-type="supplementary-material"}), increased renal thickness ratios for cortex/total and cortex/medulla (Fig. [S3C,D](#sd1){ref-type="supplementary-material"}), decreased the renal fibrosis related parameters (Fig. [S3E--J](#sd1){ref-type="supplementary-material"} and [L--O](#sd1){ref-type="supplementary-material"}), and inhibited renal tubule atrophy (Fig. [S3K,P](#sd1){ref-type="supplementary-material"}), decreased inflammatory cell infiltration and related inflammatory factors (Fig. [S4A--F](#sd1){ref-type="supplementary-material"}), and decreased the levels of intracellular ROS, whereas the mRNA levels of Gpx1, Gpx4, and GSR were up-regulated significantly (Fig. [S4G--I](#sd1){ref-type="supplementary-material"}).

Renal redox imbalance is not ameliorated by deletion of *p16* in *Bmi-1*^*-/-*^ mice
------------------------------------------------------------------------------------

To exclude the possibility that *Bmi-1*, which suppresses the *p16*^*INK4a*^-senescence pathway, simply prevented cells from entering senescence where ROS is produced at high levels and the levels of the antioxidant enzymes are low, we examined the ROS levels and mRNA levels of antioxidant enzymes in the kidneys obtained from *Bmi-1*^*-/-*^ mice or from *Bmi-1*^*-/-*^*p16*^*-/-*^ mice. Results showed that ROS levels and mRNA levels of antioxidant enzymes were not altered significantly in *Bmi-1*^*-/-*^*p16*^*-/-*^ mice when compared with *Bmi-1*^*-/-*^ mice (Fig. [S5A--C](#sd1){ref-type="supplementary-material"}). Thus, redox imbalance of *Bmi-1*^*-/-*^ mice is not caused by the *p16*^*INK4a*^-senescence pathway up-regulation.

Discussion
==========

In this study, we demonstrated that Bmi-1 deficiency resulted in renal interstitial fibrosis, tubular atrophy, and severe renal function impairment with decreased renal cell proliferation, increased renal cell apoptosis and senescence, and inflammatory cell infiltration. These phenotypic features were consistent with the typical histological (Yang & Fogo, [@b43]) and functional alterations (Fliser *et al*., [@b18]) of renal tubulointerstitial injury. Our results also demonstrated that renal tubulointerstitial injury caused by Bmi-1 deficiency was largely rescued by antioxidant treatment. These findings indicate that Bmi-1 plays a critical role in the protection from renal tubulointerstitial injury by maintaining redox balance.

Previous studies suggest that the degree of renal tubulointerstitial injury is positively correlated with an oxidative stress increase after renal transplantation (Djamali, [@b16]). This study therefore examined whether renal tubulointerstitial injury which occurred in Bmi-1-deficient mice was associated with impaired mitochondria and increased oxidative stress. We found that mitochondrial structure was impaired in Bmi-1-deficient mice. Results from a previous study support that the mitochondria are the major source of increased ROS levels observed in Bmi-1-deficient cells (Liu *et al*., [@b26]). It was shown from previous results that Bmi-1 deficiency leads to an increased p53 accumulation at promoters and to gene repression of antioxidant genes through recruitment of corepressors (Chatoo *et al*., [@b11]). Our results also revealed that increased oxidative stress, including dramatically increased the levels of intracellular ROS, H~2~O~2~, and MDA, in Bmi-1-deficient kidneys resulted from decreased levels of these endogenous antioxidants, including significantly down-regulating the activities of T-SOD and CAT, the mRNA levels of Gpx1 and CAT, SOD2 and Prdx1, and the protein levels of SOD2 and Prdx1. Consequently, impaired mitochondrial structure and incited oxidative stress with reduced levels and activity of antioxidant enzymes, observed in Bmi-1-deficient kidneys, may contribute to the pathogenesis of renal tubulointerstitial injury.

Previous observations have demonstrated that oxidative stress can trigger activation of the DNA damage response (DDR) pathway (Lombard *et al*., [@b27]). The current study further demonstrated the DDR pathway occurred in Bmi-1-deficient kidneys, including significant increases in γ-H2A.X, 8-OHdG, 53Bp1, and pChk2-positive renal cells, the up-regulation of protein expression levels of γ-H2A.X, pChk2, p53, and p21 in kidneys, decreased renal cell proliferation, and increased renal cell apoptosis and senescence. Our results were similar to those induced by ROS (Liu *et al*., [@b26]; Shao *et al*., [@b36]), suggesting that increased oxidative stress caused by Bmi-1 deficiency can activate DDR in kidney.

DDR induces not only apoptosis and cell senescence, but also chronic inflammation via NF-κB-dependent pro-inflammatory cytokine production by senescent cells (Aoshiba *et al*., [@b2]). In the current study, we demonstrated that increased renal cell senescence caused by Bmi-1 deficiency was associated with up-regulation of NF-κB, IL-6, and TNF-α expression at both the gene and protein levels and increased CD11b-positive myeloid cells, CD3e-positive T cells, and granulomas. These results indicate that tubular atrophy occurring in Bmi-1-deficient kidney was not only the result of decreased renal cell proliferation and increased renal cell apoptosis, but also associated with increased renal cell senescence and inflammatory cell infiltration following increased oxidative stress and DNA damage.

Several lines of evidence suggest that the activation of TGF-β signaling contributes to kidney fibrosis (Liu, [@b25]; Lan, [@b23]). Overexpression of active TGF-β in mice is sufficient to induce the development of tubulointerstitial fibrosis (Bottinger & Kopp, [@b7]), and inhibition of TGF-β activity attenuates renal disease in experimental models of renal fibrosis (Liu, [@b25]). Therefore, we examined whether the renal interstitial fibrosis caused by Bmi-1 deficiency was associated with the activation of TGF-β signaling. Our results revealed that TGF-β1/Smad signaling was activated in the Bmi-1-deficient kidney, including significant up-regulation of active TGF-β1, pSmad2/3, Smad4, and TGF-β1 type II receptor (TGF-βRII). In view of the fact that Ang II can directly stimulate crosstalk of compounds in the TGF-β1 pathway, activate the release of active TGF-β1 from the latent complex, and up-regulate TGF-βRII by mediating transcriptional activity of the receptor gene (Ruster & Wolf, [@b34]), we also examined the alterations of RAAS in the Bmi-1-deficient kidney and found that Bmi-1 deficiency resulted in significant increases in mRNA expression levels of renin and angiotensinogen, plasmic Ang II, and ALD levels. Our results suggest that the renal interstitial fibrosis occurring in Bmi-1-deficient mice was associated with the activation of the RAAS-TGF-β1/Smad signaling pathway. However, how Bmi-1 regulates these signalings remains to be investigated.

Tubulointerstitial fibrosis is characterized by excessive accumulation of ECM, which results from increased synthesis and/or decreased degradation of ECM (Rhyu *et al*., [@b32]). ECM synthesis is mainly produced by consistently activated myofibroblasts labeled with α-SMA (Samarakoon *et al*., [@b35]). The decline in ECM degradation was caused by the decreased expression of MMPs, increased expression of TIMPs, and decreased proportions of MMPs/TIMPs (Boffa *et al*., [@b5]; Catania *et al*., [@b10]). PAI-1 directly promotes infiltration of macrophages and T cells and subsequently activates myofibroblasts to produce more ECM (Dussaule *et al*., [@b17]; Samarakoon *et al*., [@b35]). In the current study, we found that the increased ECM accumulation in Bmi-1-deficient kidney, including increased positive areas of total collagen, Masson's trichrome-labeled interstitial fibers, type I collagen, and fibronectin, was associated with decreased MMP9 expression, increased TIMP1, TIMP2, and PAI-1 expression, and decreased ratios of MMP2/TIMP2 and MMP9/TIMP1. Recent literature has provided evidence suggesting that the EMT process is involved in several pathophysiological conditions, including organ fibrosis (Cannito *et al*., [@b8]). TGF-β1, as the most potent inducer of EMT, initiates and directs the entire EMT course, mainly through the TGF-β1/Smad signal pathway in renal fibrogenesis (Liu, [@b25]). It was shown from previous results that Bmi-1 inhibits the TGF-β1/Smad pathway by suppressing active TGF-β1 expression and Smad2/3 phosphorylation (Kim *et al*., [@b22]). Results from the previous reports regarding the effect of Bmi-1 on EMT are not consistent. Bmi-1 induces EMT in nasopharyngeal epithelial cells, and suppression of Bmi-1 in nasopharyngeal carcinoma cells reverses EMT (Song *et al*., [@b38]). However, Bmi-1 overexpression in MCF10A cells did not induce the EMT phenotype (Datta *et al*., [@b13]). Therefore, Bmi-1-induced EMT may be a cell type-specific function (Song *et al*., [@b38]). In this study, we also examined whether renal interstitial fibrosis caused by Bmi-1 deficiency was associated with oxidative stress-induced EMT by knocked down Bmi-1 in human renal proximal tubular cell epithelial (HK2) cells. Our results demonstrated that Bmi-1 deficiency induced HK2 cells to mesenchymal transition, including the up-regulation of α-SMA expression and the down-regulation of E-cadherin expression, by increased intracellular ROS and decreased antioxidative enzyme gene expression. Results from the present study indicate that the tubulointerstitial fibrosis caused by Bmi-1 deficiency is associated with the imbalance of ECM synthesis and the degradation and induction of EMT.

Previous pathological analysis revealed that the impairment of renal function correlates better with the extent of tubulointerstitial injury than with the degree of glomerular damage (Mackensen-Haen *et al*., [@b28]; Nath, [@b31]). Tubulointerstitial injury induces a decrease in glomerular filtration rate (GFR) via several mechanisms. Tubular atrophy increases fluid delivery to the macula densa and triggers a reduction in GFR via tubuloglomerular feedback (Bohle *et al*., [@b6]). Tubular damage also leads to atubular glomeruli and decreases the number of functional nephrons and the obliteration of postglomerular capillaries, leading to ischemic renal injury (Marcussen, [@b29]). The PSV is a semiquantitative measure of intrarenal blood flow on spectral Doppler imaging, is strongly associated with renal vascular compliance and resistance, and is correlated with renal function and histological damage scores (Gao *et al*., [@b19]; Chen *et al*., [@b12]). In this study, we found that impaired renal function occurred in the Bmi-1-deficient kidney, including decreased peak systolic velocity of renal arteries, down-regulated 1α(OH)ase and EPO gene expression due to weakened renal endocrine secretion, decreased SCrCl and UCr, and increased SCr, SUN, and urinary albumin due to GFR reduction. Renal tubulointerstitial injury caused by Bmi-1 deficiency consequently resulted in severe renal function impairment.

NAC, an essential precursor to many endogenous antioxidants involved in the decomposition of peroxides, attenuates oxidative stress by replenishing intracellular glutathione stores (Small *et al*., [@b37]). NAC pretreatment reduced endothelial dysfunction caused by uremic toxins by reducing ROS-dependent expression of NF-κB (Tumur *et al*., [@b41]). NAC reduced kidney MDA levels in a mouse model of diabetic nephropathy (Ribeiro *et al*., [@b33]). In clinical trials, NAC improves lung function in patients with chronic obstructive pulmonary disease, highlighting the potential benefit of ROS-directed therapy (Demedts *et al*., [@b14]). The current study confirmed that antioxidant treatment prolonged the lifespan and increased the body size of Bmi-1-deficient mice. Furthermore, we demonstrated that renal tubulointerstitial injury caused by Bmi-1 deficiency was largely rescued by antioxidant treatment by improving mitochondrial structure, reducing oxidative stress and DNA damage, increasing renal cell proliferation, decreasing renal cell apoptosis, senescence and inflammatory cell infiltration, ameliorating ECM accumulation and EMT by inhibiting RAAS-TGF-β1/Smad signaling; consequently, improving renal function. PQQ, as another antioxidant and cell signaling factor, modulates mitochondrial quantity and function in mice (Stites *et al*., [@b40]). To further ensure that renal tubulointerstitial injury caused by Bmi-1 deficiency was due to oxidative damage to tissues and cells, *Bmi-1*^-/-^ mice were treated with PQQ. Results demonstrated that the PQQ treatment also largely rescued the renal tubulointerstitial injury caused by Bmi-1 deficiency, comparably to the treatment of NAC. To exclude the possibility that *Bmi-1*, which suppresses the *p16*^*INK4a*^-senescence pathway, simply prevented cells from entering senescence where ROS is produced at high level and the levels of the antioxidant enzymes are low, we deleted *p16* in *Bmi-1*^*-/-*^ mice and examined alterations of ROS levels and mRNA levels of antioxidant enzymes in kidneys. Our results demonstrated that the deletion of *p16* in *Bmi-1*^*-/-*^ mice did not alter ROS levels and mRNA levels of antioxidant enzymes, suggesting that the redox imbalance which occurred in *Bmi-1*^*-/-*^ mice did not result from the *p16*^*INK4a*^-senescence pathway up-regulation. Consequently, our results support the hypothesis that the action of Bmi-1 in maintaining redox balance is critical for the protection from renal tubulointerstitial injury.

Bmi-1 is not only involved in mitochondrial function maintenance and DNA protection from damage, it is also involved in cell cycle regulation and cell senescence by inhibiting p16^INK4a^/Rb and p19^AFR^/p53 pathways (Zhang *et al*., [@b45]). Our results confirmed that the expression levels of p16, p19, p53, and p21 proteins were up-regulated significantly in Bmi-1-deficient kidney and down-regulated by the treatment of NAC. However, the gene expression levels of p16, p19, p53, p21, cyclin D1, and CDK4 were regulated insignificantly in the Bmi-1-deficient kidney with NAC treatment. These results suggest that p16 and p19 signal molecules are regulated by antioxidants at post-transcriptional levels. However, the exact regulating mechanism of antioxidants on these molecules remains to be investigated.

In conclusion, this study demonstrated that renal tubulointerstitial injury with renal function impairment caused by Bmi-1 deficiency was associated with impaired mitochondrial structure, increased oxidative stress, DNA damage, renal cell apoptosis and senescence, inflammatory cell infiltration, decreased renal cell proliferation, imbalance between ECM synthesis and degradation, and enhanced EMT, whereas these phenotypic alterations were largely rescued by antioxidant treatment. Results from this study indicate that Bmi-1 plays a critical role in protection from renal tubulointerstitial injury by maintaining redox balance. Our findings imply that Bmi-1 is a novel therapeutic target for renal tubulointerstitial injury.

Experimental procedures (Appendix S1)
=====================================

Mice and genotyping
-------------------

Adult Bmi-1 heterozygote (*Bmi-1*^+/−^) mice (129Ola/FVB/N hybrid background) were backcrossed 10--12 times to the C57BL/6J background and mated to generate Bmi-1 homozygote (*Bmi-1*^*-/-*^) and their wild-type (WT) littermates genotyped by PCR, as described previously (Zhang *et al*., [@b45]; Cao *et al*., [@b9]). *P16*^*Ink4*α+/−^ mice on the FVB N2 background were crossed to *Bmi-1*^+/−^ mice to generate double knockout (*Bmi-1*^*-/-*^*p16*^*-/-*^) mice. This study was carried out in strict accordance with the guidelines of the Institute for Laboratory Animal Research of Nanjing Medical University. The protocol was approved by the Committee on the Ethics of Animal Experiments of Nanjing Medical University (Permit Number: BK2006576).

Cell line and cell cultures
---------------------------

The HK2 (human renal proximal tubular epithelial cell line) (American Type Culture Collection) was cultured as previously described (Yang *et al*., [@b44]).

Small interference RNA-mediated knockdown of human Bmi-1
--------------------------------------------------------

For small interference RNA (siRNA) experiments, RNA primers complementary to human Bmi-1 were designed and synthesized by the Ribobio Co. Ltd. in China. siRNAs were transfected using the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions (Bai *et al*., [@b3]). After incubation for 72 or 96 h, cells were harvested and mRNA and protein were detected by RT--PCR, real-time RT--PCR, or immunocytochemistry stain. Sequences of siRNAs and targeted mRNAs are in Table [S1](#sd2){ref-type="supplementary-material"} (Supporting information).

Administration of N-acetylcysteine and pyrro-quinoline quinone
--------------------------------------------------------------

*In vivo,* NAC was administered according to Liu J (Liu *et al*., [@b26]).

*In vitro*, HK2 cells with Bmi-1 siRNA1 were incubated without or with NAC at 1 m[m]{.smallcaps} (0.163 mg mL^−1^) after transfection until changes were detected at the mRNA levels (Ambrogini *et al*., [@b1]).

*In vivo,* PQQ-supplemented diet (4 mg PQQ/kg diet) (Beijing cooperation Feed Co. Ltd., China) was administered as previously described (Steinberg *et al*., [@b39]).

Preparation of renal sections
-----------------------------

Mice were anesthetized with 3% pentobarbital sodium (40 mg kg^−1^) at 5 weeks of age. Renal specimens were perfused with 100 mL normal sodium and then perfused and fixed with periodate--lysine--paraformaldehyde (PLP) solution (for histochemistry or immunohistochemistry) or 1% glutaraldehyde (for conventional electron microscopy). Kidneys were dissected for detection of light or electron microscopy as previously described (Zhang *et al*., [@b45]; Jin *et al*., [@b21]; Cao *et al*., [@b9]).

Histochemical or immunohistochemical and immunocytochemistry stains
-------------------------------------------------------------------

Pre-embedding senescence-associated-β-gal (SA-β-gal), HE, and picrosirius red (Li *et al*., [@b24]) for total collagen histochemistry stains were performed following previously described methods (Jin *et al*., [@b21]).

Masson's trichrome staining was performed with a D026 Masson detection kit from Nanjing Jiancheng Bioengineering Institute in China according to the manufacturer's instructions.

Immunohistochemical staining was performed following previously described methods (Jin *et al*., [@b21]). Primary antibodies against type Ι collagen (Southern Biotech, Birmingham, AL, USA), α-SMA (Abcam, Cambridge, MA, USA), fibronectin (Sigma, St. Louis, MO, USA), E-cadherin (Santa Cruz Biotechnology, Inc., Dallas, TX, USA), Ki67 (Abcam), NF-κB-p65 (Cell Signaling Technology, Beverly, MA, USA), TNF-α (Santa Cruz Biotechnology, Inc.) IL-6 (Santa Cruz Biotechnology, Inc.), γ-H2A.X (Ser139) (Cell Signaling Technology), 8-hydroxyguanosine (8-OhdG) (Abcam), 53Bp1 (Novus Biological, Littleton, CO, USA), and pCHK2 (Thr68) (Abcam) were used.

For immunocytochemistry staining, cells seeded on coverslips were fixed with PLP solution for 45 min, blocked for endogenous peroxidase (3% H~2~O~2~), and pre-incubated with serum. Primary antibodies against α-SMA (Abcam) or E-cadherin (Santa Cruz Biotechnology, Inc.) were used.

TUNEL assay
-----------

Dewaxed and rehydrated paraffin sections were stained with an *In Situ* Cell Death Detection Kit (Roche Diagnostics Corp., Basel, Switzerland) using a previously described protocol (Jin *et al*., [@b21]).

Flow cytometry analysis
-----------------------

### Intracellular ROS analysis

For analysis of intracellular ROS, total renal cells from 5-week-old mice were incubated with 5 m[m]{.smallcaps} diacetyldichlorofluorescein (DCFDA) (Invitrogen) and placed in a shaker at 37 °C for 30 min, followed immediately by flow cytometry analysis in a FACScalibur flow cytometer (Becton Dickinson, Heidelberg, Germany) and/or fluorescence microscope (Liu *et al*., [@b26]).

### Surface labeling

Single-cell suspensions of kidneys from 5-week-old mice were analyzed by flow cytometry using mAb targeting CD11b \[phycoerythrin (PE) conjugated\] or CD3e (PE-Cy^TM7^ conjugated) from BD Biosciences.

Color Doppler flow imaging of kidneys
-------------------------------------

Mice were anesthetized with 3% pentobarbital sodium (40 mg kg^−1^) and depilated in abdominal region at 5 weeks. A high frequency ultrasound imaging system for small animal research (Vevo 2100, Visualsonics, Toronto, Canada) equipped with the MS-400 transducer of 24 MHz central frequency was used for detecting peak systolic velocity (PSV) of renal arteries. Renal interlobular arteries were sampled by pulse Doppler following previously described methods (Yang & Chiu, [@b42]).

RNA isolation and real-time RT--PCR
-----------------------------------

RNA was isolated from kidneys of 5-week-old mice or HK2 cells using Trizol reagent (Invitrogen) according to the manufacturer's protocol. Sample mRNA levels were semiquantified by RT--PCR or quantified by real-time RT--PCR as previously described (Jin *et al*., [@b21]). PCR primers are in Table [S2](#sd2){ref-type="supplementary-material"} (Supporting information).

Western blot
------------

Western blot analyses of kidney samples from 5-week-old mice were performed following previously described methods (Jin *et al*., [@b21]). Primary antibodies against α-SMA (Abcam), E-cadherin (Santa Cruz Biotechnology, Inc.), Akt (Santa Cruz Biotechnology, Inc.), phospho-Akt (pAkt) (Santa Cruz Biotechnology, Inc.), Bcl-2 (Santa Cruz Biotechnology, Inc.), caspase-3 and phospho-caspase-3 (Cell signaling technology), p16 (Santa Cruz Biotechnology, Inc.), p19 (Santa Cruz Biotechnology, Inc.), p53 (Cell Signaling Technology), p21 (Santa Cruz Biotechnology, Inc.), SOD1 (Abcam), SOD2 (Novus Biological), Prdx1 (Santa Cruz Biotechnology, Inc.), γ-H2A.X (Ser139) (Cell Signaling Technology), CHK2 (Novus Biological), pCHK2 (Novus Biological), TGF-β1 precursor (Abcam)-activated TGF-β1 (Abcam) TGF-βRII (Santa Cruz Biotechnology, Inc.), pSmad2/3 (Santa Cruz Biotechnology, Inc.), Smad4 (Millipore, Billerica, MA, USA), angiotensin II (Novus Biological, Inc.), Bmi-1 (Millipore), or β-actin (Bioworld Technology, St. Louis Park, MN, USA) were used.

Biochemical measurements
------------------------

### Oxidative stress levels

Renal tissues from 5-week-old mice were homogenized in cold saline. Homogenate (10%) was centrifuged at 4000 rpm at 4 °C for 10 min. Supernatant was used for measurements of hydrogen peroxide (H~2~O~2~) (A064 H~2~O~2~ detection kit), total superoxide dismutase (T-SOD) (A001-1 SOD detection kit) catalase (CAT) (A007 CAT detection kit), and malondialdehyde (MDA) (A003-1 MDA detection kit). Detection kits were from Nanjing Jiancheng Bioengineering Institute in China. All examinations were performed according to the manufacturer's instructions.

### Urinary creatinine and urea albumin

At 5 weeks of age, mice were placed in metabolic cages the day before sacrificing and given water but not food. Urine was collected for 24 h before sacrificing and used to measure urinary creatinine (UCr) (C011 Cr detection kit) and urinary albumin (UAL) (A028 UAL detection kit) according to the manufacturer's instructions (Nanjing Jiancheng Bioengineering Institute, China).

### Levels of serum urea nitrogen and serum creatinine

At 5 weeks of age, mice were anesthetized with 3% pentobarbital sodium (40 mg kg^−1^) and depilated in the abdominal region. Blood was taken by suction from the heart with a 1-mL syringe. Serum was isolated for measurements of urea nitrogen (SUN) (C013-2 SUN detection kit) and serum creatinine (SCr) (C011 Cr detection kit) according to the manufacturer's instructions (Nanjing Jiancheng Bioengineering Institute, China). Hominal serum creatinine clearance (SCrCl) was analyzed by the Cockcroft-Gault equation: SCrCl = \[(140 - age) (year) \* body mass (kg)\]/\[0.818\* SCr ([m]{.smallcaps})\] (Michels *et al*., [@b30]). The SCrCl level of Bmi-1^-/-^ mice relative to the SCrCl level of WT littermates was assessed by the equation: \[Bmi-1^-/-^ body mass (g)/WT body mass (g)\] \* \[WT SCr ([m]{.smallcaps})/Bmi-1^-/-^ SCr ([m]{.smallcaps})\]:1.

### Levels of plasma angiotensin II and aldosterone

Plasma renin, angiotensin II (Ang II), and aldosterone (ALD) concentrations from 5-week-old mice were determined using commercial radioimmunoassay kits according to the manufacturer's instructions (Beijing North Institute of Biological Technology, China).

Hematocrit measurements
-----------------------

Blood (20 μL) was collected in heparinized microhematocrit capillary tubes and spun at 3000 *g* for 5 min at room temperature. Hematocrits were measured by the equation: Hematocrit (%) = \[the height of red blood cells (mm)\]/\[the height of whole blood (mm)\] (Dilauro *et al*., [@b15]).

Statistical analysis
--------------------

All analyses were performed using [spss]{.smallcaps} software (Version 16.0, SPSS Inc., Chicago, IL, USA). Measured data were described as mean ± SEM fold-change over control and analyzed by Student's *t*-test and one-way [anova]{.smallcaps} to compare differences between groups. Qualitative data were described as percentages and analyzed using a chi-square test as indicated. *P*-values were two-sided, and \<0.05 was considered statistically significant.
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**Fig. S1** Western blots of kidney extracts for expressions of (A) α-SMA, (C) γ-H2A.X, CHK2, pCHK2, (E) p16, p19, p53 and p21. (B) α-SMA, (D) γ-H2A.X, CHK2, pCHK2, (F) p16, p19, p53 and p21 protein levels relative to β-actin protein levels were assessed by densitometric analysis. β-actin was used as a loading control.

**Fig. S2** Enhanced EMT induced by oxidative stress were ameliorated by NAC treatment in *Bmi-1*-knockdown HK2 cells.

**Fig. S3** Renal interstitial fibrosis and tubule atrophy are ameliorated by pyrro-quinoline quinone (PQQ) treatment in *Bmi-1*^*-/-*^ mice.?

**Fig. S4** Renal tubulointerstitial inflammation and redox imbalance were ameliorated by pyrro-quinoline quinone (PQQ) treatment in *Bmi-1*^*-/-*^ mice.

**Fig. S5** Renal redox imbalance is not ameliorated by deletion of *p16* in *Bmi-1*^*-/-*^ mice (*Bmi-1*^*-/-*^*p16*^*-/-*^).
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**Table S1** siRNAs against human Bmi-1.

**Table S2** Primers for RT--PCR and Real-time RT--PCR.

**Table S3** Lifetime survival studies.
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**Appendix S1** Complete experimental procedures and references.
